Mebendazole-treated human monocyte-derived dendritic cells represent promoted immunogenic phenotype with augmented expression of inflammatory markers.
MBZ holds significant potential for reshaping immunotherapy by exerting a profound impact on dendritic cells. By comprehending the intricate interaction between MBZ and dendritic cell function, innovative interventions can be developed.
Authors
- Sepideh Sohrabi (ORCID: https://orcid.org/0009-0004-2736-3896)
- Vahid Khaze (ORCID: https://orcid.org/0000-0001-6160-5925)
- Amirhossein Mardi (ORCID: https://orcid.org/0000-0001-5305-6364)
- Behzad Baradaran (ORCID: https://orcid.org/0000-0002-8642-6795)
- Elham Baghbani (ORCID: https://orcid.org/0000-0002-7529-108X)
- Negin Karamali (ORCID: https://orcid.org/0000-0003-3753-4260)
- Shiva Alipour (ORCID: https://orcid.org/0000-0002-4596-2508)
Institutions
- Tabriz University of Medical Sciences (IR)
Publication Details
- Journal
- Advanced Pharmaceutical Bulletin
- Published
- 2025-10-11
- DOI
- https://doi.org/10.34172/apb.025.43394
- Citations
- 1
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- Tabriz University of Medical Sciences
- University of Tabriz
- National Institute for Medical Research Development